Judge Trims J&J Investor Suit Over Kids' Meds Recalls

Law360, New York (December 19, 2011, 9:35 PM EST) -- A New Jersey federal judge on Monday pared a putative shareholder class action accusing Johnson & Johnson of failing to disclose manufacturing violations that led to several recalls of popular children's medications and caused the health care company's stock to tank.

U.S. District Judge Freda L. Wolfson dismissed claims against William Weldon, CEO of J&J, and Peter Luther, president of J&J subsidiary McNeil-PPC Inc., saying the plaintiff's allegations regarding the executives' intentions to mislead investors were conclusory.

The judge, however, allowed claims against Colleen Goggins, the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

MONK v. JOHNSON & JOHNSON et al


Case Number

3:10-cv-04841

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Freda L. Wolfson

Date Filed

September 21, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.